Ferdinand Investment Partners advised Fagron on the acquisition of Magilab, acting on the buy side of the transaction

‍

Fagron, a global personalized medicine company, acquired Magilab, a Hungary-based supplier of magistral pharmaceutical ingredients and laboratory services. The transaction had reached an advanced stage when the due diligence process stalled, leaving key financial areas unresolved close to signing.

Ferdinand took over within 48 hours, rebuilt the core analyses from audited financial data and management inputs, and delivered a full-scope financial due diligence within two weeks. The work included Quality of Earnings analysis, EBITDA normalization, working capital assessment, and focused review of customer concentration and inventory risk, with outputs structured to feed directly into valuation discussions and SPA-stage negotiations.

At signing, the seller attempted to re-open the purchase price based on a revised EBITDA forecast. Ferdinand delivered counter-analysis grounded in the completed financial work, allowing the buyer to maintain its position. The acquisition was completed within the originally agreed valuation range.

‍

About Ferdinand Investment Partners 

Ferdinand Investment Partners is an independent M&A and corporate finance advisory firm operating across Hungary, Romania, and the broader CEE region. The firm advises mid-market companies on buy-side and sell-side transactions, capital and debt advisory, corporate finance, financial due diligence, and business development with senior partners directly involved at every stage of each mandate. 

‍

About Fagron

Fagron is a global pharmaceutical compounding company founded in the Netherlands in 1990, currently operating in 35 countries. The company enables pharmacists, prescribers, hospitals, and healthcare providers to prepare individually tailored medications through pharmaceutical compounding and sterile outsourcing services, extending the range of commercially available treatments and keeping medicines accessible for patients whose needs cannot be met by standardized products.

‍

About Magilab

Magilab Kft. is a Budapest-based supplier of magistral pharmaceutical ingredients, established in 2017 as a wholly owned subsidiary of Hungaropharma Zrt. The company holds the largest accumulated expertise in the qualification, packaging, and distribution of magistral pharmaceutical raw materials in Hungary, serving compounding pharmacies and hospitals from a GMP-compliant facility.

‍